• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Suprachoroidal Space Shows Promise As Location for Delivering Treatment | AAO 2023


Delivering medication in the suprachoroidal space would be less invasive than intravitreal injections used to deliver many eye treatments.

Positive results for suprachoroidal delivery of an Investigational gene therapy for diabetic retinopathy were reported on Friday at the annual meeting of the American Academy of Ophthalmology meeting in San Francisco.

Suber S. Huang, M.D., MBA, of the Retina Center of Ohio in Cleveland and a member of the panel of discussants at the session for late-breaking research, says one of the takeaways from that research is that the suprachoroidal space looks to be promising location for delivering ophthalmic medications.

The suprachoroidal space is a potential space between the sclera, the protective membrane that wraps around most of the eyeball and gives the eyeball its white appearance and choroid, a thin layer of tissue composed mainly of blood vessels that is sandwiched between the sclera and the retina on the back side of the eye.

The study results are “yet another indication that a suprachoroidal approach without the need for vitrectomy or working under the retinal or direct intravitreal injection may be a useful option in our management armamentarium,” said Huang.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.